Q2 STOCKS TO BUY

MannKind Stock Makes Moves on Milestone Payment

Short sellers have targeted MNKD stock

Digital Content Manager
Apr 1, 2019 at 9:58 AM
facebook X logo linkedin


Biopharmaceutical concern MannKind Corporation (NASDAQ:MNKD) is volatile today, after the company received a $12.5 million milestone payment from United Therapeutics (UTHR). The payment is part of a collaboration agreement -- worth up to $37.5 million in milestone payments for MNKD -- to develop and commercialize MNKD's hypertension treatment as a dry powder formula. After jumping 1.5% out of the gate,  the shares were last seen down 2.5% at $1.92.

The equity rallied hard off its December low of $0.94, and hit a six-month high of $2.34 on March 20. The shares have since pulled back below the $2 mark -- a 23.6% Fibonacci retracement of that recent surge, and a layer of resistance last June and October. The penny stock is still up 81.5% year-to-date, though. 

While analysts are relatively quiet on MannKind, the two brokerages that do follow the drugmaker give it "buy" and "strong buy" ratings. Plus the consensus 12-month target price of $3.50 represents an 82.3% premium to current levels, and sits in an area not seen since January 2018. 

Short sellers, meanwhile, have piled on their bearish bets. Short interest rose 5.4% in the latest reporting period, and now accounts for a solid 21.6% of the stock's available float, or 10 times the security's average daily trading volume.

 

 
 

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade.  Professional traders have rushed into the market and are making a mint.  Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.

 

 
 

FREE Report Download

 

Follow us on X, Follow us on Twitter